Proposed: Trial of Vitamin Derivative to Prevent Melanoma Proposed: Trial of Vitamin Derivative to Prevent Melanoma

The vitamin B3 derivative nicotinamide was previously shown to reduce nonmelanoma skin cancers in a phase 3 trial.Medscape Medical News

Source: Medscape Medical News Headlines - August 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news